For instance, EGFRL858R/exon19Δ predicts a high propensity of bone and pleura metastases in a group of treating naïve patients with lung adenocarcinoma in late IV stage, while tumour cells with ALK rearrangement are more prone to metastasize to the liver.25 The gene discussed is ALK; the disease is lung adenocarcinoma.